{"id":9347,"date":"2025-04-09T12:39:38","date_gmt":"2025-04-09T10:39:38","guid":{"rendered":"https:\/\/shams-alyaoum.com\/en\/?p=9347"},"modified":"2025-04-09T12:39:38","modified_gmt":"2025-04-09T10:39:38","slug":"hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena","status":"publish","type":"post","link":"https:\/\/shams-alyaoum.com\/en\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\/","title":{"rendered":"Hikma signs exclusive licensing agreement with pharma&amp; to bring innovative oncology treatment to MENA"},"content":{"rendered":"<p><span lang=\"EN-GB\">Hikma Pharmaceuticals PLC\u00a0(Hikma), the multinational pharmaceutical company, has announced an exclusive licensing agreement with pharmaand GmbH (pharma&amp;), a global pharmaceutical company based in Vienna, Austria.<\/span><\/p>\n<p><span lang=\"EN-GB\">This agreement grants Hikma exclusive rights to commercialise\u00a0rucaparib\u00a0across the Middle East and North Africa (MENA) region. Rucaparib, marketed as Rubraca\u00ae, is an innovative small-molecule oral therapy designed to inhibit poly (ADP-ribose) polymerases (PARPs), a family of proteins critical to DNA repair in cancer cells. This mechanism makes rucaparib an important treatment option for patients battling ovarian cancer, the 8th<\/span>\u00a0<span lang=\"EN-GB\">most common cancer in women globally[1], and prostate cancer, the 4th\u00a0most common cancer worldwide and the second most common cancer in men[2].<\/span><\/p>\n<p>&nbsp;<\/p>\n<p><span lang=\"EN-GB\">Rucaparib has received regulatory approval from both the European Medicines Agency (EMA) and the United States Food and Drug Administration (U.S. FDA).<\/span><\/p>\n<p><span lang=\"EN-GB\">Mazen Darwazah, Hikma\u2019s Executive Vice Chairman and President of MENA, said<\/span><span lang=\"EN-GB\">: \u201cWe are pleased to add rucaparib, an innovative oncology treatment, to our growing oncology portfolio in MENA. This agreement is a major step to further enhance patients\u2019 access to life-changing treatments and address critical medical needs across the region. By strengthening our oncology portfolio, we reaffirm our commitment to providing advanced cancer treatments and supporting our purpose of putting better health within reach, every day.\u201d<\/span><\/p>\n<p>As the company\u2019s first\u00a0<span lang=\"EN-GB\">innovative<\/span>\u00a0small-molecule oral therapy in oncology approved by both the U.S. FDA and EMA, this partnership strengthens Hikma\u2019s promise of providing be<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Hikma Pharmaceuticals PLC\u00a0(Hikma), the multinational pharmaceutical company, has announced an exclusive licensing agreement with pharmaand GmbH (pharma&amp;), a global pharmaceutical company based in Vienna, Austria. This agreement grants Hikma exclusive rights to commercialise\u00a0rucaparib\u00a0across the Middle East and North Africa (MENA) region. Rucaparib, marketed as Rubraca\u00ae, is an innovative small-molecule oral therapy designed to inhibit poly &hellip;<\/p>\n","protected":false},"author":2,"featured_media":9348,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17,2],"tags":[9,1310,1280],"class_list":["post-9347","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-economy","category-news","tag-business","tag-general","tag-technology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Hikma signs exclusive licensing agreement with pharma&amp; to bring innovative oncology treatment to MENA - Magazine Shams Al Yaoum<\/title>\n<meta name=\"description\" content=\"Hikma Pharmaceuticals PLC\u00a0(Hikma), the multinational pharmaceutical company, has announced an exclusive licensing agreement with pharmaand GmbH\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/shams-alyaoum.com\/en\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hikma signs exclusive licensing agreement with pharma&amp; to bring innovative oncology treatment to MENA - Magazine Shams Al Yaoum\" \/>\n<meta property=\"og:description\" content=\"Hikma Pharmaceuticals PLC\u00a0(Hikma), the multinational pharmaceutical company, has announced an exclusive licensing agreement with pharmaand GmbH\" \/>\n<meta property=\"og:url\" content=\"https:\/\/shams-alyaoum.com\/en\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\/\" \/>\n<meta property=\"og:site_name\" content=\"Magazine Shams Al Yaoum\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-09T10:39:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/shams-alyaoum.com\/en\/wp-content\/uploads\/2025\/04\/Hikma-logo_1738239212.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"666\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"shamsalyaoum\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"shamsalyaoum\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/shams-alyaoum.com\\\/en\\\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/shams-alyaoum.com\\\/en\\\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\\\/\"},\"author\":{\"name\":\"shamsalyaoum\",\"@id\":\"https:\\\/\\\/shams-alyaoum.com\\\/en\\\/#\\\/schema\\\/person\\\/6e4dae56c61a28d2d84c342a9a53d199\"},\"headline\":\"Hikma signs exclusive licensing agreement with pharma&amp; to bring innovative oncology treatment to MENA\",\"datePublished\":\"2025-04-09T10:39:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/shams-alyaoum.com\\\/en\\\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\\\/\"},\"wordCount\":256,\"image\":{\"@id\":\"https:\\\/\\\/shams-alyaoum.com\\\/en\\\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/shams-alyaoum.com\\\/en\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/Hikma-logo_1738239212.jpg\",\"keywords\":[\"Business\",\"General\",\"Technology\"],\"articleSection\":[\"Economy\",\"NEWS\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/shams-alyaoum.com\\\/en\\\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\\\/\",\"url\":\"https:\\\/\\\/shams-alyaoum.com\\\/en\\\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\\\/\",\"name\":\"Hikma signs exclusive licensing agreement with pharma&amp; to bring innovative oncology treatment to MENA - Magazine Shams Al Yaoum\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/shams-alyaoum.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/shams-alyaoum.com\\\/en\\\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/shams-alyaoum.com\\\/en\\\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/shams-alyaoum.com\\\/en\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/Hikma-logo_1738239212.jpg\",\"datePublished\":\"2025-04-09T10:39:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/shams-alyaoum.com\\\/en\\\/#\\\/schema\\\/person\\\/6e4dae56c61a28d2d84c342a9a53d199\"},\"description\":\"Hikma Pharmaceuticals PLC\u00a0(Hikma), the multinational pharmaceutical company, has announced an exclusive licensing agreement with pharmaand GmbH\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/shams-alyaoum.com\\\/en\\\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/shams-alyaoum.com\\\/en\\\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/shams-alyaoum.com\\\/en\\\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\\\/#primaryimage\",\"url\":\"https:\\\/\\\/shams-alyaoum.com\\\/en\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/Hikma-logo_1738239212.jpg\",\"contentUrl\":\"https:\\\/\\\/shams-alyaoum.com\\\/en\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/Hikma-logo_1738239212.jpg\",\"width\":1000,\"height\":666},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/shams-alyaoum.com\\\/en\\\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/shams-alyaoum.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hikma signs exclusive licensing agreement with pharma&amp; to bring innovative oncology treatment to MENA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/shams-alyaoum.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/shams-alyaoum.com\\\/en\\\/\",\"name\":\"Magazine Shams Al Yaoum\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/shams-alyaoum.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/shams-alyaoum.com\\\/en\\\/#\\\/schema\\\/person\\\/6e4dae56c61a28d2d84c342a9a53d199\",\"name\":\"shamsalyaoum\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/11774fd6260846ea4d3230345b47c868eaffb0fe76386b1a8b3cc24c8dc91f3d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/11774fd6260846ea4d3230345b47c868eaffb0fe76386b1a8b3cc24c8dc91f3d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/11774fd6260846ea4d3230345b47c868eaffb0fe76386b1a8b3cc24c8dc91f3d?s=96&d=mm&r=g\",\"caption\":\"shamsalyaoum\"},\"url\":\"https:\\\/\\\/shams-alyaoum.com\\\/en\\\/author\\\/shamsalyaoum\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hikma signs exclusive licensing agreement with pharma&amp; to bring innovative oncology treatment to MENA - Magazine Shams Al Yaoum","description":"Hikma Pharmaceuticals PLC\u00a0(Hikma), the multinational pharmaceutical company, has announced an exclusive licensing agreement with pharmaand GmbH","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/shams-alyaoum.com\/en\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\/","og_locale":"en_US","og_type":"article","og_title":"Hikma signs exclusive licensing agreement with pharma&amp; to bring innovative oncology treatment to MENA - Magazine Shams Al Yaoum","og_description":"Hikma Pharmaceuticals PLC\u00a0(Hikma), the multinational pharmaceutical company, has announced an exclusive licensing agreement with pharmaand GmbH","og_url":"https:\/\/shams-alyaoum.com\/en\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\/","og_site_name":"Magazine Shams Al Yaoum","article_published_time":"2025-04-09T10:39:38+00:00","og_image":[{"width":1000,"height":666,"url":"https:\/\/shams-alyaoum.com\/en\/wp-content\/uploads\/2025\/04\/Hikma-logo_1738239212.jpg","type":"image\/jpeg"}],"author":"shamsalyaoum","twitter_card":"summary_large_image","twitter_misc":{"Written by":"shamsalyaoum","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/shams-alyaoum.com\/en\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\/#article","isPartOf":{"@id":"https:\/\/shams-alyaoum.com\/en\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\/"},"author":{"name":"shamsalyaoum","@id":"https:\/\/shams-alyaoum.com\/en\/#\/schema\/person\/6e4dae56c61a28d2d84c342a9a53d199"},"headline":"Hikma signs exclusive licensing agreement with pharma&amp; to bring innovative oncology treatment to MENA","datePublished":"2025-04-09T10:39:38+00:00","mainEntityOfPage":{"@id":"https:\/\/shams-alyaoum.com\/en\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\/"},"wordCount":256,"image":{"@id":"https:\/\/shams-alyaoum.com\/en\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\/#primaryimage"},"thumbnailUrl":"https:\/\/shams-alyaoum.com\/en\/wp-content\/uploads\/2025\/04\/Hikma-logo_1738239212.jpg","keywords":["Business","General","Technology"],"articleSection":["Economy","NEWS"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/shams-alyaoum.com\/en\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\/","url":"https:\/\/shams-alyaoum.com\/en\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\/","name":"Hikma signs exclusive licensing agreement with pharma&amp; to bring innovative oncology treatment to MENA - Magazine Shams Al Yaoum","isPartOf":{"@id":"https:\/\/shams-alyaoum.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/shams-alyaoum.com\/en\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\/#primaryimage"},"image":{"@id":"https:\/\/shams-alyaoum.com\/en\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\/#primaryimage"},"thumbnailUrl":"https:\/\/shams-alyaoum.com\/en\/wp-content\/uploads\/2025\/04\/Hikma-logo_1738239212.jpg","datePublished":"2025-04-09T10:39:38+00:00","author":{"@id":"https:\/\/shams-alyaoum.com\/en\/#\/schema\/person\/6e4dae56c61a28d2d84c342a9a53d199"},"description":"Hikma Pharmaceuticals PLC\u00a0(Hikma), the multinational pharmaceutical company, has announced an exclusive licensing agreement with pharmaand GmbH","breadcrumb":{"@id":"https:\/\/shams-alyaoum.com\/en\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/shams-alyaoum.com\/en\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/shams-alyaoum.com\/en\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\/#primaryimage","url":"https:\/\/shams-alyaoum.com\/en\/wp-content\/uploads\/2025\/04\/Hikma-logo_1738239212.jpg","contentUrl":"https:\/\/shams-alyaoum.com\/en\/wp-content\/uploads\/2025\/04\/Hikma-logo_1738239212.jpg","width":1000,"height":666},{"@type":"BreadcrumbList","@id":"https:\/\/shams-alyaoum.com\/en\/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/shams-alyaoum.com\/en\/"},{"@type":"ListItem","position":2,"name":"Hikma signs exclusive licensing agreement with pharma&amp; to bring innovative oncology treatment to MENA"}]},{"@type":"WebSite","@id":"https:\/\/shams-alyaoum.com\/en\/#website","url":"https:\/\/shams-alyaoum.com\/en\/","name":"Magazine Shams Al Yaoum","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/shams-alyaoum.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/shams-alyaoum.com\/en\/#\/schema\/person\/6e4dae56c61a28d2d84c342a9a53d199","name":"shamsalyaoum","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/11774fd6260846ea4d3230345b47c868eaffb0fe76386b1a8b3cc24c8dc91f3d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/11774fd6260846ea4d3230345b47c868eaffb0fe76386b1a8b3cc24c8dc91f3d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11774fd6260846ea4d3230345b47c868eaffb0fe76386b1a8b3cc24c8dc91f3d?s=96&d=mm&r=g","caption":"shamsalyaoum"},"url":"https:\/\/shams-alyaoum.com\/en\/author\/shamsalyaoum\/"}]}},"_links":{"self":[{"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/posts\/9347","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/comments?post=9347"}],"version-history":[{"count":1,"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/posts\/9347\/revisions"}],"predecessor-version":[{"id":9349,"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/posts\/9347\/revisions\/9349"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/media\/9348"}],"wp:attachment":[{"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/media?parent=9347"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/categories?post=9347"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/tags?post=9347"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}